WHO approves emergency use of 'Covaxin'

Daily Current Affairs / WHO approves emergency use of 'Covaxin'

Change Language English Hindi

Category : National Published on: November 05 2021

Share on facebook

Bharat Biotech's Covaxin has got WHO approval as the technical advisory team has recommended the India-made vaccine for emergency use listing for 18 years and above.
This marks a major victory for India's journey in vaccination against Covid-19.
Covaxin is a vaccine, completely 'made in India', by Hyderabad-based Bharat Biotech and the Indian Council of Medical Research.
Covaxin has demonstrated 77.8 per cent effectiveness against symptomatic COVID-19 and 65.2 per cent protection against the new Delta variant.

R. Praggnanandhaa wins UzChess Cup Masters 2025 and becomes top-ranked Indian chess player.
Read More....
Meesho gets shareholder approval to raise ₹4,250 crore via IPO after shifting domicile to India.
Read More....
IPS officer Parag Jain appointed new RAW chief; played key role in Operation Sindoor.
Read More....
ICC updates powerplay rules for shortened T20 matches effective from July 2025.
Read More....
Power Ministry forms task force to develop 'India Energy Stack' for digital power infrastructure.
Read More....
MNRE issues revised guidelines for Biomass Programme to promote clean energy adoption.
Read More....
CBSE to hold Class 10 board exams twice a year from 2026 session; first phase mandatory, second optional.
Read More....
NATO agrees to increase defence spending target to 5% of GDP by 2035 at The Hague summit.
Read More....
India and South Africa sign agreements on submarine cooperation during defence talks.
Read More....
Odisha wins women’s title in first Hockey India Masters Cup; Tamil Nadu enters men’s final.
Read More....

WHO approves emergency use of 'Covaxin'